Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
4-oxo Docosahexaenoic acid is an active metabolite of docosahexaenoic acid (Item No. 90310).1 It is formed from docosahexaenoic acid by 5-lipoxygenase (5-LO). 4-oxo Docosahexaenoic acid is an agonist of peroxisome proliferator-activated receptor γ (PPARγ).2 It induces gene transcription in a reporter assay using COS-1 cells expressing PPARγ (EC50 = ~10 µM). 4-oxo Docosahexaenoic acid (100 µM) decreases the proliferation of MDA-MB-231, BT-549, T47D, and SK-BR-3 breast cancer cells, MCF-10F breast epithelial cells, and increases the proliferation of MCF-7 breast cancer cells.3
WARNING This product is not for human or veterinary use.
1. Lipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer. Sci. Rep. 11(1), 410 (2021).
2. Structural basis for the activation of PPARγ by oxidized fatty acids. Nat. Struct. Mol. Biol. 15(9), 924-931 (2008).
3. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. In Vitro Cell. Dev. Biol. Anim. 51(2), 121-127 (2015).